Low-dose intravenous plus inhaled versus intravenous polymyxin B for the treatment of extensive drug-resistant Gram-negative ventilator-associated pneumonia in the critical illnesses: a multi-center matched case–control study

BACKGROUND: The mortality of extensively drug-resistant Gram-negative (XDR GN) bacilli-induced ventilator-associated pneumonia (VAP) is extremely high. The purpose of this study was to compare the efficacy and safety of inhaled (IH) plus intravenous (IV) polymyxin B versus IV polymyxin B in XDR GN b...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jiao, Shao, Min, Xu, Qianghong, Liu, Fen, Pan, Xiaojun, Wu, Jianfeng, Xiong, Lihong, Wu, Yueming, Tian, Mi, Yao, Jianying, Huang, Sisi, Zhang, Lidi, Chen, Yizhu, Zhang, Sheng, Wen, Zhenliang, Du, Hangxiang, TaoWang, Liu, Yongan, Li, Wenzhe, Xu, Yan, Teboul, Jean-louis, Chen, Dechang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357592/
https://www.ncbi.nlm.nih.gov/pubmed/35934730
http://dx.doi.org/10.1186/s13613-022-01033-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357592/
https://www.ncbi.nlm.nih.gov/pubmed/35934730
http://dx.doi.org/10.1186/s13613-022-01033-5

Ejemplares similares